Resilience: The Science of Mastering Life's Greatest Challenges
Tuesday, July 9, 2013
Watch Video Recording:
Presented by
Dennis S. Charney, M.D.
Icahn School of Medicine at Mount Sinai
Scientific Council Member Emeritus
Dr. Charney studies the neurobiology and treatment of mood and anxiety disorders. His investigations have yielded fundamental contributions to the understanding of neural circuits, neurochemistry and functional neuroanatomy of the regulation of mood and anxiety and the psychobiological mechanisms of human resilience to stress. He led a team who determined that the biology of human anxiety disorders was characterized by excessive noradrenergic activity and dysfunction in specific neural circuits, including the prefrontal cortex, amygdala, and hippocampus. His work in depression led to new hypotheses regarding the mechanisms of antidepressant drugs and the discovery of novel therapies for treatment-resistant depression, such as lithium and ketamine, which have been shown to work within hours.
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy Award-nominated public television program “Healthy Minds,” and serves as host of the series. The program, which is broadcast nationwide, focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association and as an Associate Clinical Professor of Psychiatry at Columbia University College of Physicians and Surgeons.
